Fundraising Fox

BigHat Biosciences

San Francisco, US · Founded 2019 · Delaware corporation · 7 known investors

bighatbio.com ↗

Big Hat Bio develops therapeutics under development across multiple programs. The company is a STEM-focused team working on therapeutic discovery and development.

AI & Machine LearningBiotechDeep Techin /bighat-biosciences@bighatbio

Founders & leadership

PGPeyton Greenside
Peyton GreensideExecutive Officer, Director
SKSteve Kafka
Steve KafkaDirector
VAVineeta Agarwala
Vineeta AgarwalaDirector
RC
Robert ChessDirector
MD
Mark DePristoExecutive Officer, Director
FGFrancisco Gimenez
Francisco GimenezDirector

Investors · 7

8VCAustin · $500K – $50M
Andreessen HorowitzMenlo Park · $500K – $50Mvia Vineeta Agarwala · board
BOLD LongevityBoston
Flucas VenturesJupiter · $100K – $5Mvia Ashley Flucas · inferred
AME Cloud VenturesreportedPalo Alto · $1M – $10M
Axial VCreportedSan Francisco · $100K – $5M
Section 32reportedPalo Alto

Reported raises · per SEC filings

Form D private placements
▶$124.1MraisedApr 2025 · 40 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Francisco GimenezDirector
  • Peyton GreensideExecutive Officer, Director
  • Steve KafkaDirector
  • Vineeta AgarwalaDirector
  • Robert ChessDirector
Offering amount
$124.1M
Amount sold
$124.1M
First sale
Jun 2022
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$18.8MraisedFeb 2021 · 6 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Peyton GreensideExecutive Officer, Director
  • Vineeta AgarwalaDirector
  • Francisco GimenezDirector
  • Mark DePristoExecutive Officer, Director
Offering amount
$19M
Amount sold
$18.8M
First sale
Jan 2021
Incorporated
Corporation, Delaware, 2019
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$5.3MraisedDec 2019 · 12 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Theresa TribblePromoter
  • Francisco GimenezDirector
  • Mark DePristoExecutive Officer, Director
  • Peyton GreensideExecutive Officer, Director
Offering amount
$5.3M
Amount sold
$5.3M
First sale
Oct 2019
Incorporated
Corporation, Delaware, 2019
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

In the news